Metraipolis › archive › dc_fcc49f654fe3

Dovramilast for Erythema Nodosum Leprosum in Patients With Leprosy in Nepal: Protocol for a Phase 2 Open-Label Pilot Study — Europe PMC PMID:42308518

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42308518
DOI
10.2196/88069
License (as archived)
solo-consultazione
Archived
2026-10-19T08:51:53.982Z
SHA-256 of the archived text
17739fe5a1fa6b1f6caa0bf0d80a1b04f385badf4e1d8290ec1d1100daa027a3
Stable URL of this page
https://metraipolis.com/documento/dc_fcc49f654fe3

How to cite

Dovramilast for Erythema Nodosum Leprosum in Patients With Leprosy in Nepal: Protocol for a Phase 2 Open-Label Pilot Study — Europe PMC PMID:42308518 — Europe PMC (en), https://europepmc.org/article/MED/42308518 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fcc49f654fe3 (Metraipolis archive dc_fcc49f654fe3, sha256 17739fe5a1fa6b1f6caa0bf0d80a1b04f385badf4e1d8290ec1d1100daa027a3)
BibTeX
@misc{dcfcc49f654fe3,
  title = {Dovramilast for Erythema Nodosum Leprosum in Patients With Leprosy in Nepal: Protocol for a Phase 2 Open-Label Pilot Study — Europe PMC PMID:42308518},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42308518},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fcc49f654fe3; sha256 17739fe5a1fa6b1f6caa0bf0d80a1b04f385badf4e1d8290ec1d1100daa027a3},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42308518. Agents can read the archived copy with the MCP tool read_document.